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Abstract
Background: Accurate staging of superficial esophageal squamous cell cancer (ESCC) for endoscopic therapy is challenging.
Optical coherence tomography (OCT) has been shown to be superior to high-resolution endoscopic ultrasound (EUS).
Volumetric Laser Endomicroscopy (VLE), a second-generation OCT, has recently become commercially available.
Objective: To assess if VLE can determine which patients with superficial ESSC can undergo endoscopic therapy.
Methods: This is a multi-center retrospective study. Patients were included if (a) they had visible ESCC, (b) they underwent
VLE and EUS for staging, and c) if superficial disease was suspected then endoscopic resection had to be performed to have
accurate histology to compare the VLE scan to. VLE scans were then compared to the gold standard: histology for superficial
disease and EUS for disease T1b and greater.
Results: Seventeen patients were included with the following disease: squamous intraepithelial neoplasia (4 patients), T1a
disease (6 patients), T1b (2 patients), T2 disease (2 patients) and T3 disease (3 patients). VLE was able to distinguish
superficial disease, defined as disease limited up to the lamina propria, from non-superficial disease in all cases.
Conclusions: VLE may be able to determine which ESCC patients are candidates for endoscopic therapy. Prospective studies
are needed to confirm this.
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Key points
. Volumetric laser endomicroscopy (VLE) is a balloon-based second-generation optical coherence
tomography technology that provides high-resolution esophageal imaging.
. Determining the depth of involvement in superﬁcial squamous esophageal cancer is diﬃcult but
necessary when selecting patients for endoscopic therapy.
. In this study of 17 patients, VLE was able to distinguish superﬁcial disease from non-superﬁcial disease in
all cases. This has implications for selecting candidates for endoscopic therapy.
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Introduction
Eighty percent of esophageal cancers occur in the
non-western world; and ninety percent of these are
esophageal squamous cell carcinoma (ESCC).1 The precursor to ESCC is squamous intraepithelial neoplasia
(SIN).2 Endoscopic therapy is accepted for ESCC and
SIN if the lesions are limited to the epithelium or
lamina propria.2,3 Surgery with or without radiation/
chemotherapy is the accepted standard if these lesions
involve the deep submucosa. Lesions limited to the
mucscularis mucosa or superﬁcial submucosa are considered a gray zone for endoscopic treatment.2,3 These
standards of therapy are based on the risk of lymph
node metastasis (LNM).4,5
Recognized endoscopic therapies include radiofrequency ablation (RFA), and resection by endoscopic
mucosal resection (EMR) or endoscopic submucosal
dissection (ESD).2,6,7 RFA has the drawback of not
obtaining histology resulting in a lack of awareness of
histologic features that may predict LNM.3 Therefore,
RFA is most eﬃcacious in patients that are low-risk for
LNM; when disease is conﬁned to the lamina propria3.
ESD may be considered for cases of deep mucosal and
early submucosal involvement, when patients are not
suitable candidates for surgery and when the risk of
LNM is considered low.
Determining which patients have ESCC limited to
the lamina propria can be challenging. In a recent retrospective study, specimens from patients that underwent
ESD for ﬂat ESCC, were examined.3 The study showed
that one-third of patients that met clinical and endoscopic criteria for RFA had histologic criteria that were
considered contraindications for RFA. The study concluded that determining which patients should receive
RFA therapy is challenging. The challenge stems
from inaccurate pre-therapy staging of ESCC.8 Highfrequency endoscopic ultrasound (HF-EUS) and EUS
are limited in imaging superﬁcial ESCC.8 However,
studies have shown that optical coherence tomography
(OCT) can produce high-resolution images of
staging ESCC. A prospective study compared OCT to
HF-EUS in 123 patients with superﬁcial ESCC and
found that OCT had a higher accuracy (95% vs 81%;
p < 0.05)8. First-generation OCT, used in that study, is
not commercially available.
Recently, second-generation OCT, termed volumetric laser endomicroscopy (VLE), has been developed
and is commercially available in the United States of
America. VLE is a second-generation OCT technology.
It is balloon-based, with the probe within a balloon that
allows for centering within the esophagus. It diﬀers
from previous versions of OCT in this regard, where
previous versions only used a probe. It uses infrared
light to produce real time high-resolution crosssectional imaging of the tubular esophagus. VLE can
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scan a 6 cm length of the esophagus in approximately
90 s, providing surface and subsurface wide-ﬁeld crosssectional imaging with an axial resolution of 7 mm to a
depth of 3 mm.9,10 It has mainly been used for dysplasia
detection in Barrett’s esophagus.9,11,12 At present,
literature on VLE use for ESCC is limited.13 The aim
of our study was to examine the potential role of VLE
for staging various SIN and ESCC lesions to determine
its appropriateness for endoscopic therapy.

Methods
This is a multi-center retrospective study from four
academic tertiary care centers in the USA (Long
Island Jewish Medical Center, New Hyde Park, NY;
Columbia University Medical Center, New York,
NY; Mayo Clinic Arizona, Scottsdale, AZ; and Weill
Cornell Medical College, New York, NY) from
January 2014 to November 2017. Institutional review
board approval was obtained from all centers from 13
June 2014 to 5 September 2017. The study protocol
conforms to the ethical guidelines of the 1975
Declaration of Helsinki as reﬂected in a prior approval
by the institution’s human research committee.
Patients were included if they (a) had visible ESCC
or SIN, (b) underwent VLE of the visible abnormalities
and (c) had EUS for staging. If superﬁcial disease was
suspected/present (deﬁned as limited up to the lamina
propria) then endoscopic resection had to be performed
to have an accurate histologic stage to compare the
VLE scan to. This was decided given the lower accuracy
of EUS for staging of superﬁcial disease.8 EMR and
ESD histology were considered the gold standard for
superﬁcial ESCC or SIN staging. EUS was the gold
standard for staging of invasive ESCC staged T1b or
greater, as this has been shown to be accurate and has
less inter-observer variability for invasive disease.8,14
Staging was performed using standard guidelines.15
Non-visible lesions were not included as the VLE
images are more challenging to correlate to endoscopy.
VLE (NvisionVLE, Ninepoint Medical, Bedford,
MA, USA) was performed in the usual manner
described in the literature9 by experienced users in
VLE (AJT, AS, NF and MK). VLE is FDA cleared
for use in the gastrointestinal (GI) tract but is marketed
mainly for use in the esophagus. The lesions in this
study were endoscopically evident as there was a
sharp contrast between normal esophageal mucosa
and diseased mucosa. All patients were referred
for endoscopic staging prior to deciding treatment.
All patients underwent high-deﬁnition white light
endoscopy with Lugol’s chromoendoscopy. VLE was
performed prior to Lugol’s staining. Locating these
lesions on VLE was straightforward as there was a
sharp contrast between normal tissue and lesions with
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ESCC or SIN. All the lesions were surrounded by
normal esophageal tissue both on high-deﬁnition
white light endoscopy with Lugol’s chromoendoscopy
and VLE. Although VLE with laser marking was available for over half of these cases, it was not performed as
the lesions in question were evident on endoscopy.
In addition to the sharp contrast seen of normal
esophagus versus abnormal ESCC or SIN (both on
endoscopy and VLE), the location of the lesions on
VLE compared to endoscopy were conﬁrmed by using
the registration lines on the VLE balloon and images.
Figure 1 depicts normal esophageal layers on
VLE. Figures 2 and 3 depict images with superﬁcial
and invasive disease, respectively. All procedures
utilized a 20 mm balloon.
This study incorporated previously recognized OCT
criteria to stage SIN and ESCC (Hatta criteria based on
probe-based OCT).16 This staging is based on OCT
signal penetration into a layer with preservation of
the layers below it. In our experience, we have noticed
that this staging is similar for VLE with SIN disease; a
surface hyperreﬂective (darker) signal from the neoplasm is visualized only involving the epithelium with
preservation of the layers below it. However, with disease involving deeper layers, a surface hyperreﬂectivity
is seen with eﬀacement (loss of the traditional layering)
below the darkened surface. The extent or depth of
disease involvement is determined by which layers are
preserved below it. This is diﬀerent from OCT staging
without a balloon, as the balloon compresses the
mucosa and creates this eﬀect. Another diﬀerence is
that the Hatta criteria deﬁne hyperreﬂective surface
signals as white and hyporeﬂective signals as black
due to how they process the image.16 The VLE literature describes darker surface signals as hyperreﬂective,9,10,17 and thus to be consistent with the VLE
literature, we did the same. After the VLE was
performed, the endoscopist interpreted the VLE

images and the ﬁndings were recorded in the endoscopy
report. The endoscopist had no knowledge of
the histology ﬁndings from EMR/ESD specimens.
For the purposes of this study, VLE images were
re-reviewed by another experienced VLE user (SI), to
ensure reliability of the VLE ﬁndings among all
sites. This user was blinded to the histology and VLE
ﬁndings during his review.
If lesions were suspected of being superﬁcial disease,
then EMR/ESD was performed of the lesion as it
provides histopathology staging and information
regarding lymphovascular invasion, which is
considered important for determining the depth of
invasion, accurate staging and prognosis.18,19 The
histology images were interpreted by an expert GI pathologist and conﬁrmed by a second GI pathologist.
The pathology ﬁndings were read independent of
the EUS and VLE ﬁndings and were read after the
endoscopy was performed.
Endoscopic ultrasound of invasive disease was performed by the same user using a radial echoendoscope
with an advanced processor (GF-UE160-AL5 and
Prosound F75, Olympus America, Center Valley, PA,
USA) using established EUS staging criteria for
ESCC.14 EUS ﬁndings were recorded on the procedure
report. VLE scans were then compared to the gold
standard to determine if a VLE pattern correlated to
the histologic stage SIN or ESCC.

Results
Seventeen patients were identiﬁed for this study.
The patients with SIN or T1a disease (patients 1–10)
had an EMR/ESD histology stage as the gold standard.
None of these patients had evidence of lymphovascular
invasion. Patients with T1b disease or greater (patients
11–17) had EUS staging as the gold standard. Based on
the gold standard, there were four patients with

SQUAMOUS
EPITHELIUM
LAMINA PROPRIA
MUSCULARIS MUCOSA

SUBMUCOSA

MUSCULARIS
PROPRIA

Figure 1. An example of normal esophageal layers and corresponding histology (not from the same patient). Image courtesy of Ninepoint
Medical.

Trindade et al.

841

Figure 2. Images from patients with T1a squamous cancer. The first column from (a)–(c) shows the endoscopic, VLE and histology images
of a patient with high-grade squamous intraepithelial neoplasia. The yellow arrow points to the lesion on endoscopy (a). The VLE image
(b) shows surface hyperreflectivity constrained to the epithelium (red arrows) with preservation of layers below. The histology (c) shows
disease limited to the to the epithelium. The second column from (d)–(f) shows the endoscopy with Lugol’s chromoendoscopy with
surrounding cautery marks outlining the lesion for resection (d), VLE and histology images of a patient with squamous cell cancer
invading the lamina propria. The VLE image (e) shows surface hyperreflectivity (red arrows) extending to the lamina propria but
preservation of the layers below it. The corresponding histology shows disease limited to the lamina propria. The third column from
(g)–(i) shows the endoscopy with Lugol’s chromoendoscopy with surrounding cautery marks outlining the lesion for resection (g), VLE
and histology images of a patient with squamous cell cancer invading the muscularis mucosae. The VLE image shows diffuse surface hyperreflectivity and effacement of all layered architecture below it. The corresponding histology shows disease limited to the
muscularis mucosae.
VLE: volumetric laser endomicroscopy.

SIN limited to the epithelium. Six patients had T1a
disease: three patients with ESCC limited to the
lamina propria and three patients with ESCC limited
to the muscularis mucosa. There were two patients with
T1b ESCC with disease limited to the submucosa.
There were two patients with disease limited to the
muscularis propria and three patients with disease
beyond the muscularis propria. The VLE and EUS
features are listed in Table 1. For the VLE ﬁndings,
there were no diﬀerences in image interpretation from
the initial interpretation in real-time compared to the
re-review by another experienced user.
With regard to the VLE ﬁndings, patients 1–4 had a
surface hyperreﬂectivity in the epithelium with

preservation of the layers below it (Figure 2). For
patients 5–7, there was surface hyperreﬂectivity extending to the lamina propria but with preservation of the
layers below it; the submucosa and layers below were
intact (Figure 2). For patients 8–17, surface hyperreﬂectivity was seen with eﬀacement of all layered architecture below it (Figures 2 and 3).
VLE was able to distinguish superﬁcial disease (disease limited to the lamina propria) from non-superﬁcial
or invasive disease in all 17 cases. In invasive disease,
deﬁned as disease extending beyond the lamina propria,
VLE had a distinct signature of surface hyperreﬂectivity with eﬀacement of all layered architecture. With
regard to tumor (T) staging, VLE could not provide a
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Figure 3. Images from patients with T2 and T3 invasive squamous cell cancer. The first column from (a)–(d) shows the endoscopy with
Lugol’s chromoendoscopy, VLE, EUS and histology images from a pinch biopsy from a patient with T2 ESCC. The VLE image (b) shows
surface hyperreflectivity and effacement of all layered architecture. The corresponding EUS shows a hypoechoic lesion involving the
muscularis propria but not invading beyond it. The second column (e)–(h) shows the endoscopy with Lugol’s chromoendoscopy, VLE, EUS
and histology of a pinch biopsy from a patient with T3 ESCC. The VLE image (f) shows surface hyperreflectivity and effacement of all
layered architecture. The corresponding EUS shows a hypoechoic lesion invading beyond the muscularis propria.
ESCC: esophageal squamous cell carcinoma; EUS: endoscopic ultrasound; VLE: volumetric laser endomicroscopy.

speciﬁc T stage in non-superﬁcial or invasive disease.
VLE was able to provide a T stage in cases of superﬁcial cancer. EUS was only able to stage disease that was
T1b or higher (Table 1). In all 17 cases, VLE was able
to determine which patients were candidates for endoscopic therapy by radiofrequency ablation compared to
the gold standard.

Discussion
This study demonstrates that VLE may accurately
determine which patients with SIN and superﬁcial
ESCC should undergo endoscopic therapy. RFA is
indicted for disease limited to the lamina propria and
endoscopic resection for deep mucosal disease. In this
study, VLE had a speciﬁc signature for SIN, ESCC
limited to the lamina propria and ESCC invading
beyond the lamina propria. Thus, VLE is able to
distinguish superﬁcial from non-superﬁcial disease in
this case series. As a result, VLE and EUS are complementary. This data suggests that patients undergoing
pre-therapy staging for ESCC should undergo
an EUS. If the EUS is inconclusive due to superﬁcial
disease, then a VLE can deﬁne the stage to determine if
endoscopic therapy is possible.
VLE can help deﬁne candidates for RFA or endoscopic resection. For example, VLE staged superﬁcial
disease in patients 1–7, who were candidates for RFA.

The later patients (patients 8–17) were not candidates
for RFA, as VLE staged more invasive disease. Disease
limited to the muscularis mucosa (patients 8–10) is a
gray zone for endoscopic treatment.2 Although RFA
cannot treat this, ESD is an option. Patients 8–10
had disease limited to the muscularis mucosa and
underwent ESD that was curative. The EUS in these
patients was non-diagnostic but the VLE was consistent
with disease beyond the lamina propria. A VLE showing non-superﬁcial disease with a negative EUS
(not showing T1b disease or greater) indicated disease
limited to the muscularis mucosa and thus indicated
candidates for ESD. None of the patients underwent
RFA in this study as EMR/ESD was performed
for staging purposes. However, RFA could be useful
in multi-focal disease or when EMR/ESD were
not available.
It should also be noted that our VLE criteria are
diﬀerent from the original Hatta criteria, given the balloon-based nature of the VLE system. The Hatta group
utilized an OCT probe that images (at a depth of
1.5 mm and an axial resolution of 11 mm) the tissue in
contact with the probe. VLE utilizes a rotating probe
within a balloon (that images at a depth of 3 mm and an
axial resolution of 7 mm) that performs 360 wide-ﬁeld
imaging of a 6 cm segment of esophagus in 90 s. The
balloon helps center the probe within the esophagus for
better imaging. It is likely that the inﬂated balloon
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Table 1. Volumetric laser endomicroscopy and endoscopic ultrasound features of patients included in this study.
Gold standard diagnosis/stage

Gold
standard test

EUS findings

VLE features
Surface hyperreflectivity constrained to
the epithelium with preservation of
layers below
Surface hyperreflectivity constrained to
the epithelium with preservation of
layers below
Surface hyperreflectivity constrained to
the epithelium with preservation of
layers below
Surface hyperreflectivity constrained to
the epithelium with preservation of
layers below
Surface hyperreflectivity extending to the
lamina propria but preservation of
the layers below it
Surface hyperreflectivity extending to the
lamina propria but preservation of
the layers below it
Surface hyperreflectivity extending to the
lamina propria but preservation of
the layers below it
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture

Patient 1

High-grade SIN limited to
epithelium

EMR

No abnormalities seen, GI
tract layers intact

Patient 2

High-grade SIN limited to
epithelium

EMR

No abnormalities seen, GI
tract layers intact

Patient 3

High-grade SIN limited to
epithelium

EMR

No abnormalities seen, GI
tract layers intact

Patient 4

High-grade SIN limited to
epithelium

EMR

No abnormalities seen, GI
tract layers intact

Patient 5

ESCC limited to lamina
propria/T1a

EMR

No abnormalities seen, GI
tract layers intact

Patient 6

ESCC limited to lamina
propria/T1a

ESD

No abnormalities seen, GI
tract layers intact

Patient 7

ESCC limited to lamina
propria/T1a

ESD

Hypoechoic lesion abutting
the submucosa

Patient 8

muscularis

ESD

muscularis

ESD

muscularis

ESD

Patient 11

ESCC limited to
mucosa/T1a
ESCC limited to
mucosa/T1a
ESCC limited to
mucosa/T1a
ESCC limited to

submucosa/T1b

EUS

Patient 12

ESCC limited to submucosa/T1b

EUS

Patient 13

ESCC limited to muscularis
propria/T2
ESCC limited to muscularis
propria/T2
ESCC beyond the muscularis
propria/T3

EUS

Patient 16

ESCC beyond the muscularis
propria/T3

EUS

Patient 17

ESCC beyond the muscularis
propria/T3

EUS

No abnormalities seen, GI
tract layers intact
No abnormalities seen, GI
tract layers intact
No abnormalities seen, GI
tract layers intact
Hypoechoic lesion limited to
the submucosa
Hypoechoic lesion limited to
the submucosa
Hypoechoic lesion limited to
the muscularis propria
Hypoechoic lesion limited to
the muscularis propria
Hypoechoic lesion extending
beyond the muscularis
propria
Hypoechoic lesion extending
beyond the muscularis
propria
Hypoechoic lesion extending
beyond the muscularis
propria

Patient 9
Patient 10

Patient 14
Patient 15

EUS
EUS

Surface hyperreflectivity with effacement
of layered architecture
Surface hyperreflectivity with effacement
of layered architecture

EMR: endoscopic mucosal resection; ESCC: esophageal squamous cell carcinoma; ESD: endoscopic submucosal dissection; EUS: endoscopic ultrasound; GI:
gastrointestinal; SIN: squamous intraepithelial neoplasia; VLE: volumetric laser endomicroscopy.

exerts a tension on the mucosa that causes eﬀacement
of layers, which is not seen in probe-based OCT.
Our study does have limitations. The relatively small
cohort and retrospective observational study design

limit this study. However, the observations noted in
this study are very compelling for a role of VLE in
the staging of superﬁcial esophageal ESCC. ESCC is
not common in the USA, and thus studying VLE for
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staging ESCC is diﬃcult. On the other hand, VLE
is not available in areas with a high prevalence
of ESCC. Thus, this series provides a unique perspective on staging superﬁcial ESCC that will be hard to
replicate. We were fortunate to have a cohort
with diverse stages from SIN, T1a, T1b, T2 and T3
disease, and thus this cohort does allow insight into
VLE staging of ESCC.
Although this study is promising for the use of VLE
in the staging of superﬁcial ESCC, future studies are
needed. Such studies need to examine the degree of
inﬂation of the balloon and the psi of the balloon in
relation to eﬀacement of the VLE image. In addition, a
larger prospective study will be needed. It will likely
require a site outside the USA, given the rarity of superﬁcial ESCC in the USA. In conclusion, this study shows
that VLE may be useful to stage superﬁcial ESCC. VLE
may be able to decide which patients are suitable candidates for endoscopic therapy.
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